ICI-170809

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameICI-170809
Drug Alias NameZM-170809ICI-170809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsPlatelet aggregation inhibitors
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsDepressive Disorder, MajorThrombosisMyocardial Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorThrombosisMyocardial Ischemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A